215 related articles for article (PubMed ID: 23789947)
1. Targeting transporters for CNS drug delivery.
Ronaldson PT
Curr Pharm Des; 2014; 20(10):1419-21. PubMed ID: 23789947
[No Abstract] [Full Text] [Related]
2. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
[TBL] [Abstract][Full Text] [Related]
3. Delivery of therapeutics to the central nervous system.
Chambers JJ
Adv Drug Deliv Rev; 2012 May; 64(7):589. PubMed ID: 22388004
[No Abstract] [Full Text] [Related]
4. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
[TBL] [Abstract][Full Text] [Related]
5. Zebrafish as a model to study drug transporters at the blood-brain barrier.
Umans RA; Taylor MR
Clin Pharmacol Ther; 2012 Nov; 92(5):567-70. PubMed ID: 23047649
[TBL] [Abstract][Full Text] [Related]
6. Strategies for drug delivery to the central nervous system by systemic route.
Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
[TBL] [Abstract][Full Text] [Related]
7. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
8. Targeting CNS transporters for treatment of neurodegenerative diseases.
Jedlitschky G; Grube M; Mosyagin I; Kroemer HK; Vogelgesang S
Curr Pharm Des; 2014; 20(10):1523-33. PubMed ID: 23789959
[TBL] [Abstract][Full Text] [Related]
9. Prodrug approaches to reduce hyperexcitation in the CNS.
Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
[TBL] [Abstract][Full Text] [Related]
10. Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis.
Abdul Razzak R; Florence GJ; Gunn-Moore FJ
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242683
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
Biddlestone-Thorpe L; Marchi N; Guo K; Ghosh C; Janigro D; Valerie K; Yang H
Adv Drug Deliv Rev; 2012 May; 64(7):605-13. PubMed ID: 22178615
[TBL] [Abstract][Full Text] [Related]
12. Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.
Stenehjem DD; Hartz AM; Bauer B; Anderson GW
Future Med Chem; 2009 Dec; 1(9):1623-41. PubMed ID: 21425983
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial approaches for the identification of brain drug delivery targets.
Stutz CC; Zhang X; Shusta EV
Curr Pharm Des; 2014; 20(10):1564-76. PubMed ID: 23789958
[TBL] [Abstract][Full Text] [Related]
14. The concept of fraction of drug transported (ft ) with special emphasis on BBB efflux of CNS and antiretroviral drugs.
Prasad B; Unadkat JD
Clin Pharmacol Ther; 2015 Apr; 97(4):320-3. PubMed ID: 25669655
[TBL] [Abstract][Full Text] [Related]
15. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.
Kadakia E; Bottino D; Amiji M
Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914
[TBL] [Abstract][Full Text] [Related]
16. Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system.
Van Bree JB; De Boer AG; Danhof M; Breimer DD
Pharm World Sci; 1993 Feb; 15(1):2-9. PubMed ID: 8485503
[TBL] [Abstract][Full Text] [Related]
17. The role of membrane transporters in drug delivery to brain tumors.
Nies AT
Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
[TBL] [Abstract][Full Text] [Related]
18. Intranasal drug delivery to the central nervous system: present status and future outlook.
Tayebati SK; Nwankwo IE; Amenta F
Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
[TBL] [Abstract][Full Text] [Related]
19. The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke.
Shah K; Abbruscato T
Curr Pharm Des; 2014; 20(10):1510-22. PubMed ID: 23789950
[TBL] [Abstract][Full Text] [Related]
20. Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.
Strazielle N; Ghersi-Egea JF
Curr Pharm Des; 2016; 22(35):5463-5476. PubMed ID: 27464721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
